FDA Inspection 1322312 — Toru Arai, MD
The FDA completed an inspection of Toru Arai, MD on May 19, 2026 in Sakai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 19, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sakai (Japan)
Additional Details
Clinical Investigator (CI)